The first section reviews the current knowledge about the neuropathology, p
athophysiology, clinical symptomatology, diagnosis and treatment of multipl
e sclerosis (MS). Where possible, the text will refer to animal models of M
S with a special emphasis on experimental autoimmune encephalomyelitis (EAE
).
EAE serves as an animal model for the human inflammatory demyelinating dise
ases of the central nervous system (CNS): acute disseminated encephalomyeli
tis (ADEM) and MS. Both the histopathological characteristics and the clini
cal picture of EAE are very similar to MS. Taken together with the fact tha
t the genetic background of the animals determines susceptibility for EAE,
it demonstrates that this model is in many aspects very reminiscent of MS.
However, EAE is an induced disease with a known autoantigen, whereas the au
toimmune nature of MS and the causative autoantigen(s) are still a matter o
f debate. Extrapolation of findings in EAE to MS should be done cautiously,
especially when immune-specific mechanisms are involved.